Stay updated with breaking news from Small Molecules. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to the new market research report "Contract Research Organization (CROs) Services Market by Type (Early phase, Clinical, Lab,...
Blueprint Medicines will dole out as much as $652 million to advance up to two protein degraders from Proteovant Therapeutics for oncology and hematology.
Merck has wandered off the beaten path to find a partner that can help it discover small molecule drug candidates against tough oncology and neurology targets.
In this product brochure, explore how the Creoptix WAVEsystem can detect and quantify biological interactions in real-time for high-quality kinetic data across a broad range of samples.
The accurate and efficient measurement of intermolecular interactions and binding events is a critical element for all manner of basic research and drug discovery programs. In this whitepaper, Creoptix highlights the features and benefits of using the waveRAPID method for fast and efficient kinetic characterization.